FDA sets up council for post-market review of vaccines, gene therapies

Wait 5 sec.

The FDA said the council is intended to improve accountability and transparency as biologic products grow increasingly complex, particularly in cell and gene therapy, a sector that has seen rapid regulatory expansion in recent years